Harshal J Profile

According to the latest publication from Meticulous Research®, the global natural food colors market is projected to reach $3.74 billion by 2031, at a CAGR of 6.8% during the forecast period 2024–2031. The growth of the natural food colors market is driven by the growing demand for organic foods, increasing awareness regarding clean-label products, the growing need to enhance product appeal, increasing R&D activities in the food & beverage sector, and the emergence of microencapsulation technology for food colors. However, the high prices of natural colors and stringent regulations on the use of food colors are expected to restrain the market’s growth.

Tokenization Market by Offering (Solutions and Services), Application (Payment Security, User Authentication, Compliance Management), Organization Size, End-use Industry (Retail, Healthcare, BFSI, Others), and Geography – Global Forecast to 2030

The Tokenization Market is expected to reach $13.23 billion by 2030, at a CAGR of 19.7% during the forecast period of 2023 to 2030. The growth of this market is attributed to the demand for secure payment, proliferation of digital payment methods, stringent PCI DSS regulations, and increasing financial fraud in e-commerce. In addition, the growing inclination toward using payment applications across various industries is expected to offer significant opportunities for the growth of this market. However, tokenization implementation adds a layer of complexity to the IT structure, which restrains the growth of this market. Furthermore, the low awareness of online payments in rural areas challenges the market’s growth. Additionally, the rising adoption of cloud-based tokenization solutions and services is a major market trend.

Population Health Management (PHM) Solutions Market by Component (Software, Services), Mode of Delivery (On Premise, Cloud and Web), End User (Healthcare Providers, Payer [Private, Public], Hospitals, Physician Groups) – Global Forecast to 2030

The Population Health Management (PHM) Solutions Market is projected to reach $75.97 billion by 2030, at a CAGR of 10.9% from 2023 to 2030. The growth of this market is driven by the increasing burden of chronic diseases coupled with the geriatric population, rising adoption of healthcare IT solutions, government focus on preventive healthcare, growing focus on building disease registries, and increasing healthcare expenses worldwide. In addition, untapped opportunities in emerging economies and the rising focus on value-based care are offering opportunities for market growth. However, patient data privacy and confidentiality issues and lack of interoperability are hindering the growth of this market to some extent.

Veterinary Rapid Diagnostic Tests Market by Product (Kits, Readers), Condition (Viral, Parasitic, Bacterial Infections), Animal (Companion [Dogs, Cats], Livestock), and End User (Clinics & Hospitals, Reference Labs, Home Testing) – Global Forecast to 2030

The Veterinary Rapid Diagnostic Tests Market is expected to record a CAGR of 8.1% from 2023 to 2030, reaching $1.1 billion by 2030. The growth of this market is driven by the increasing prevalence of zoonotic diseases, the advantages of rapid tests over other testing methods, the growing preference for at-home and farm testing, rising awareness regarding veterinary health, increasing global animal health expenditure, and the increasing demand for animal-derived food products.

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User – Global Forecast to 2030

The Single-use Bioreactors Market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% from 2023 to 2030. The growing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, rising pharmaceutical R&D expenditures, the rising adoption of biosimilars, and the growing prevalence of chronic diseases are the factors driving the growth of this market.

Prebiotics Market by Ingredient (Inulin, Fructo Oligosaccharides, Galacto Oligosaccharides, Mannan Oligosaccharides), Application (Food & Beverages {Dairy Products, Beverages, Infant Food Products}, Dietary Supplements), and Geography – Global Forecast to 2029

The Prebiotics Market is projected to reach $6.61 billion by 2029, at a CAGR of 7.6% during the forecast period 2022–2029. The growth of this market is driven by the increasing consumption of prebiotics, the rising demand for nutraceuticals, and the increasing demand for plant-based food ingredients. However, the lack of awareness regarding the health benefits of prebiotics restrains the growth of this market. The growing use of prebiotics in infant formulas is expected to create growth opportunities for the players operating in this market. Additionally, the growing demand for natural, organic, and clean-label ingredients is a major trend in the global prebiotics market.

Oncology Information Systems Market By Offering (Software {Patient Information, Treatment Planning} Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) – Global Forecast to 2030

The Oncology Information Systems Market is projected to reach $4.45 billion by 2030, at a CAGR of 7.4% from 2024 to 2030. The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.

Conversational AI Market Size, Share, Forecast, & Trends Analysis by Offering, Application, Organization Size, Deployment Mode, Sector (IT & Telecommunications, BFSI, Retail & E-commerce, Healthcare & Life Sciences, Travel & Hospitality, Education, Manufacturing) – Global Forecast to 2031

The Conversational AI Market is projected to reach $54.1 billion by 2031, at a CAGR of 23.9% from 2024 to 2031. The growth of the conversational AI market is driven by the surge in demand for conversational AI solutions to improve call center operations and the proliferation of voice-enabled devices. Furthermore, the high potential of AI-enabled voice assistants in the healthcare industry and the increasing proliferation of conversational AI solutions for sales and marketing management are expected to create growth opportunities for the players operating in the conversational AI market.

Life Science Equipment Market Size, Share, Forecast, & Trends Analysis By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Microarray, Centrifuge) End User – Global Forecast to 2031

The Life Science Equipment Market is expected to reach $97.96 billion by 2031, at a CAGR of 6.3% during the forecast period 2024-2031. The growth of the life science equipment market is attributed to increasing pharmaceutical and biotech R&D expenditures, government initiatives supporting life sciences R&D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution.

Nematicides Market Size, Share, Forecast, & Trends Analysis by Type (Chemical {Fumigant}, Biological {Microbial [Bacillus sp]}, Biochemical), Form, Nematode Type (Root-knot, Cyst), Mode of Application (Seed Treatment), Crop Type – Global Forecast to 2031

The Nematicides Market is expected to reach $3.97 billion by 2031, at a CAGR of 9.3% during the forecast period 2024-2031. The growth of this market can be attributed to several factors, including the rising demand for organic foods, growing environmental concerns, and market players’ focus on product launches and acquisitions. However, the lack of awareness and low adoption of bionematicides and stringent and non-standardized regulations restrain the growth of this market. Moreover, emerging markets in Asia-Pacific and Latin America and the growing adoption of biological seed treatments are expected to generate growth opportunities for the players operating in this market.